$10 Co-pay Card Offer | Aggrenox® (aspirin/extended-release dipyridamole) 25 mg/200 mg capsules

Important Safety Information

Prescribing Information

0 0 Aggrenox Sitemobilization All 1280 03

0 0 Aggrenox Sitemobilization All 1280 05

Sign Up for Your $10 Co-pay Card

If you’re away from your computer, simply provide your email address below and we’ll send you a link to the registration form—so you can sign up later. To learn more about eligibility and program details, see full Terms and Conditions.

If you’re eligible, you can use your card to pay $10 on each of your next 24 monthly prescriptions of AGGRENOX (maximum savings of $100 per month) through December 31, 2014. See full Terms and Conditions. You’ll also be enrolled in Taking Smart Steps™, a free support program.

TERMS AND CONDITIONS

If you’re a commercially insured or cash-paying patient, pay no more than $10 with a maximum savings of $100 per monthly prescription over 24 months.

To qualify for this offer, your out-of-pocket expense must be greater than $10 per prescription. If your out-of-pocket expenses for a 1-month supply are $110 or less, you will pay $10 for a 1-month supply.

You are not eligible if prescriptions are paid by any state or federally funded programs, including, but not limited to, Medicare or Medicaid, Medigap, VA or DOD, or TriCare.

The card is not valid for Massachusetts residents or where otherwise prohibited by law.

The card cannot be combined with any other rebate or coupon, free trial, or similar offer for the specified prescription.

The card will be accepted only at participating pharmacies. The card is not health insurance.

This offer is valid only in the United States and Puerto Rico.

The card must be activated by December 31, 2012. Offer valid for 24 redemptions, to be filled by December 31, 2014. Limit 1 card per patient.

You must present this card to your pharmacist along with your prescription to participate in the program. If you have any questions regarding your eligibility or benefits, or if you wish to discontinue your participation, call the AGGRENOX Co-pay Card program at 1-855-277-2335 (8:00 AM-8:00 PM ET, Monday-Friday). Boehringer Ingelheim Pharmaceuticals, Inc. reserves the right to rescind, revoke, or amend this offer at any time without notice.

Important Safety Information

Aggrenox^® (aspirin/extended-release dipyridamole) 25 mg/200 mg capsules should be avoided in patients allergic to any ingredient in AGGRENOX, allergic to non-steroidal anti-inflammatory drugs (NSAIDS), or who have the combination of asthma, runny nose and nasal polyps. AGGRENOX should not be given to a child or teenager due to the risk of Reye’s syndrome.

AGGRENOX may cause an increased bleeding risk, including into the brain, stomach or intestines and any bleeding may take longer to stop. AGGRENOX should be avoided in patients with a history of stomach ulcers or those who drink three or more alcoholic drinks a day due to the risk of bleeding. Patients should inform their doctor of all medications they are currently taking including NSAIDS or blood thinners.

AGGRENOX should be avoided during pregnancy, especially in the third trimester, or in patients with severe liver or kidney problems. The most common side effects of AGGRENOX are headache, upset stomach and diarrhea.

What is AGGRENOX?
AGGRENOX is a prescription medication used to lower the risk of stroke in people who have had a “mini-stroke” (transient ischemia attack or TIA) or stroke due to a blood clot.

You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Click here for full Prescribing Information including Patient Information.

NEED HELP PAYING FOR AGGRENOX?
Our patient assistance program may be able to help. Call 1-800-556-8317 to find out more.

Privacy Policy | Terms of Use | Contact Us | Full Site

Content intended for U.S. residents only.
Copyright © 2012 - 2015 Boehringer Ingelheim Pharmaceuticals, Inc. All rights reserved.

Use of this Site is subject to the Internet Site Legal Notices and Disclaimers and Privacy Policy.

AG181704CONS

Important Safety InformationREAD MORE

AGGRENOX should be avoided in patients allergic to any ingredient in AGGRENOX, allergic to non-steroidal anti-inflammatory drugs (NSAIDS), or who have the combination of asthma, runny nose and nasal polyps. AGGRENOX should not be given to a child or teenager due to the risk of Reye’s syndrome.

AGGRENOX may cause an increased bleeding risk, including into the brain, stomach or intestines and any bleeding may take longer to stop. AGGRENOX should be avoided in patients with a history of stomach ulcers or those who drink three or more alcoholic drinks a day due to the risk of bleeding. Patients should inform their doctor of all medications they are currently taking including NSAIDS or blood thinners.

AGGRENOX should be avoided during pregnancy, especially in the third trimester, or in patients with severe liver or kidney problems. The most common side effects of AGGRENOX are headache, upset stomach and diarrhea.

AGGRENOX is a prescription medication used to lower the risk of stroke in people who have had a “mini-stroke” (transient ischemia attack or TIA) or stroke due to a blood clot.